These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38241964)

  • 1. Changes in markers of inflammation and their correlation with death in patients with COVID-19 in the intensive care unit.
    de Azambuja Pias Weber A; Viero FT; Pillat MM; de Lima Gonçalves T
    Cytokine; 2024 Mar; 175():156509. PubMed ID: 38241964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the inflammatory response to COVID-19 illness in pregnancy.
    Forrest AD; Poliektov NE; Easley KA; Michopoulos V; Ravi M; Cheedarla N; Neish AS; Cheedarla S; Roback JD; Dunlop AL; Badell ML; Dude CM
    Cytokine; 2023 Oct; 170():156319. PubMed ID: 37544133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
    Gadotti AC; de Castro Deus M; Telles JP; Wind R; Goes M; Garcia Charello Ossoski R; de Padua AM; de Noronha L; Moreno-Amaral A; Baena CP; Tuon FF
    Virus Res; 2020 Nov; 289():198171. PubMed ID: 32979474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
    Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
    Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients.
    Mansoor S; Butt AR; Bibi A; Mushtaq S; Ullah I; Alshahrani F; Khan A; Mansoor A
    PLoS One; 2023; 18(9):e0291332. PubMed ID: 37756264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher pro-inflammatory cytokines IL-6 and IFN-γ are associated with anti-SARS-CoV-2 spike protein-specific seroconversion in renal allograft recipients.
    Yadav B; Prasad N; Kushwaha RS; Patel MR; Bhadauria D; Kaul A
    Transpl Infect Dis; 2023 Oct; 25(5):e14133. PubMed ID: 37605477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients.
    Mazaheri T; Ranasinghe R; Al-Hasani W; Luxton J; Kearney J; Manning A; Dimitriadis GK; Mare T; Vincent RP
    PLoS One; 2022; 17(5):e0266652. PubMed ID: 35500008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of interferon gamma release assay to measure t-cell response in COVID-19 patients from intensive care units and inpatient departments.
    Khairullah Sedeeq Z; Samadzade R; Turk Dagi H; Bengi Celik J; Ural O; Findik D
    Bratisl Lek Listy; 2024; 125(9):533-538. PubMed ID: 38989757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds.
    Elnosary ME; Shreadah MA; Ashour ML; Nabil-Adam A
    Int Immunopharmacol; 2024 Jan; 126():111072. PubMed ID: 38006751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact understanding of exosome therapy in COVID-19 and preparations for the future approaches in dealing with infectious diseases and inflammation.
    Nasiri Z; Soleimanjahi H; Baheiraei N; Hashemi SM; Pourkarim MR
    Sci Rep; 2024 Mar; 14(1):5724. PubMed ID: 38459174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients.
    Elbadawy HM; Khattab A; El-Agamy DS; Eltahir HM; Alhaddad A; Aljohani FD; Almuzaini TM; Abouzied MM; Aldhafiri A
    J Clin Lab Anal; 2023 Apr; 37(7):e24881. PubMed ID: 37096731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory laboratory findings associated with severe illness among hospitalized individuals with COVID-19 in Medan, Indonesia: a cross-sectional study.
    Darmadi D; Pakpahan C; Ruslie RH; Rezano A
    F1000Res; 2021; 10():1246. PubMed ID: 35136584
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
    Smail SW; Babaei E; Amin K; Abdulahad WH
    Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery.
    Kumar NP; Venkataraman A; Nancy A; Moideen K; Varadarjan P; Selladurai E; Sangaralingam T; Selvam R; Thimmaiah A; Natarajan S; Ramasamy G; Hissar S; Radayam Ranganathan U; Babu S
    J Infect Dis; 2022 Sep; 226(7):1215-1223. PubMed ID: 35932220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of clinical outcome, laboratory findings and inflammatory cytokines levels using plasmapheresis therapy in severe COVID-19 cases.
    Hassaniazad M; Vahedi MS; Samimagham HR; Gharibzadeh A; Beyranvand S; Abbasi H; Nikpoor AR
    Respir Med; 2021; 189():106669. PubMed ID: 34757278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study.
    Tufa A; Gebremariam TH; Manyazewal T; Getinet T; Webb DL; Hellström PM; Genet S
    Front Immunol; 2022; 13():964179. PubMed ID: 35958594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes.
    Guo J; Lin WW; Zucker JE; Nandakumar R; Uhlemann AC; Wang S; Shivakoti R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1961-e1968. PubMed ID: 34999821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.